Infusion Pumps Market

Request for customization Inquire Before Buying

Infusion Pumps Market Size, Share and Industry Analysis Report By Product Type (Syringe pumps, Ambulatory pumps, Volumetric pumps, Insulin pumps, Enteral pumps, PCA pumps and Pump Accessories); By Application (Application (Chemotherapy/Oncology, Paediatrics/Neonatology, Analgesia, Gastroenterology, Pain Management, Haematology and Diabetes); By Setting (Hospitals, Home Care Settings, Ambulatory Care Settings, Academic and Research Institutes) - Forecast Year 2024 – 2031

Healthcare // Drug Delivery Devices

Number of Pages: 264 Report Format: pdf Report ID: ZBA-390 Publishing Date: - October, 2022

Frequently Ask Question

The Global Infusion Pumps Market Is Forecasted To Grow At A Rate Of 8.1% To USD 28.94 Billion In 2029.

Key Factors That Are Driving The Market Growth Include Rising demand for ambulatory infusion pumps in home care settings, Increasing incidence of chronic diseases along with the rapid growth of the geriatric population, Growing number of surgical procedures performed

The Infusion Pumps Market Is Led By Device Type Segment And Is Projected To Account For The Largest Size Of The Infusion Pumps Market From 2022 To 2029.

Some Key Players Operating In The Infusion Pumps Market Include Avanos Medical, Inc., B. Braun Melsungen Ag, Baxter International Inc., Becton, Dickinson And Company, Codan Medizinische Geräte Gmbh & Co Kg, Epic Medical, Fresenius Kabi, Icu Medical, Infutronix Solutions Llc, Insulet Corporation, Jms Co., Ltd., Medtronic Plc, Micrel Medical Devices Sa, Mindray Medical International Limited, Moog Inc., Nipro Corporation, Roche Diagnostics, Shenzhen Medrena Biotech Co., Ltd., Smiths Medical, Sooil Development Co., Ltd., Tandem Diabetes Care, Inc., Teleflex, Inc., Terumo Corporation, Ypsomed Holding Ag, Zyno Medical Llc